Application and comparison of different criteria used for the diagnosis of type IIi hyperlipoproteinemia
Denmacker, P.N.; Vos-Janssen, H.E.; Stuyt, P.M.; Schade, R.W.; Jansen, A.P.; van 't Laar, A.
Clinical Chemistry 24(9): 1445-1451
1978
ISSN/ISBN: 0009-9147 PMID: 210980 Document Number: 133580
Document emailed within 1 workday
Related Documents
Bolzano, K.; Krempler, F.; Schellenberg, B.; Schlierf, G. 1979: A comparison of bezafibrate and clofibrate in type Ii B and type IV hyperlipoproteinemia Acta Medica Austriaca 6(3): 90-94Arntz, H.R.; Klemens, U.H.; Vollmar, L.J.; Lang, P.D. 1978: Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia Medizinische Klinik 73(49): 1731-1737
Sznajderman, M. 1984: Comparison of the hypolipemic effects of bezafibrate and fenofibrate in patients with hyperlipoproteinemia type II and IV Przeglad Lekarski 41(7): 493-499
Andersen, G.E.; Friis-Hansen, B. 1976: Neonatal diagnosis of familial type Ii hyperlipoproteinemia Pediatrics 57(2): 214-220
Shepherd, J.; Packard, C.J.; Dryburgh, F.J.; Third, J.L. 1975: Diagnosis of type IIi hyperlipoproteinemia by chromatography of plasma lipoproteins on columns containing agarose Clinical Chemistry 21(13): 1887-1889
Wessels, G. 1977: Hyperlipoproteinemia type V Fredrickson. a rare metabolic disorder, its diagnosis and therapy, as demonstrated on an own case Die Medizinische Welt 28(3): 136-137
Bobilewicz, D.; Kotlicka, J.; Grajnert, K. 1981: Preliminary evaluation of the usefulness of determination of apolipoprotein B. cholesterol and VLDL triglyceride concentrations in the early diagnosis of type IV hyperlipoproteinemia Polski Tygodnik Lekarski 36(9): 325-326
Akiskal, H.S. 1980: External validating criteria for psychiatric diagnosis: their application in affective disorders Journal of Clinical Psychiatry 41(12 Part 2): 6-15
Krittayaphong, R.; Nomsawadi, V.; Muenkaew, M.; Miniphan, M.; Yindeengam, A.; Udompunturak, S. 2013: Accuracy of ECG criteria for the diagnosis of left ventricular hypertrophy: a comparison with magnetic resonance imaging Journal of the Medical Association of Thailand 96(Suppl 2): S124-S132
Heckers, H.; Oehler, G. 1975: Type-V-hyperlipoproteinemia Die Medizinische Welt 26(39): 1766-1774
Calderín, F.M.; Perianes, J.; Nuño, J.; De Oya, M. 1977: Hyperlipoproteinemia type i Revista Clinica Espanola 147(1): 81-84
Bustos, P.; Fernández, E.; Radrigán, E. 1987: Hyperlipoproteinemia type i Revista Chilena de Pediatria 58(6): 481-484
Matsuura, F. 2007: Familial hyperlipoproteinemia, type IV Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 7): 326-328
Morrone, G.; Franco, G.; Di Muccio, G.; Cappello, A. 1978: A case of type IV hyperlipoproteinemia La Pediatria 86(4): 667-677
Papaian, A.V.; Fedorova, Z.D.; Val'kovich, E.I.; Slobozhankina, I.K.; Odesskaia, T.A. 1975: Experimental determination of criteria of diagnosis and success of heparin treatment of generalized intravascular coagulation of the type of Sanarelli-Schwartzman phenomenon Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 1: 35-40
Di Gruttola, G.; Ferrara, M. 1977: Familial congenital type IIB hyperlipoproteinemia La Pediatria 85(3): 435-442
Schoenborn, W.; Fuhrmann, W.; Huth, K. 1973: Hyperlipoproteinemia type 3 in kidney diseases Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 1280-1283
Masket, B.H.; Levy, R.I.; Fredrickson, D.S. 1973: The use of polyacrylamide gel electrophoresis in differentiating type 3 hyperlipoproteinemia Journal of Laboratory and Clinical Medicine 81(5): 794-802
Mertz, D.P.; Suermann, I.; Göhmann, E. 1978: Clofibrate in type IIa hyperlipoproteinemia. Reduction of apolipoprotein B Münchener Medizinische Wochenschrift 120(34): 1097-1099
Hagve, T.A.; Furuset, T.; Christophersen, B.; Ose, L. 1993: Apolipoprotein e phenotyping--useful in the study of hyperlipoproteinemia type IIi Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 113(7): 853-856